Class III beta-Tubulin in Advanced NSCLC of Adenocarcinoma Subtype Predicts Superior Outcome in a Randomized Trial

Adam Christian Vilmar, Eric Santoni-Rugiu, Jens Benn Sorensen

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageUndefined/Unknown
JournalClinical Cancer Research
ISSN1078-0432
DOIs
Publication statusPublished - 2011

Cite this